Scientific Sessions 2024  /  Meet the Trialist: ZODIAC  /  Meet the Trialist: ZODIAC: Pragmatic Randomized Controlled Trial of a Decision Support System to Aid Physician Optimization of Early Lipid Lowering Therapies after Acute Coronary Syndrome
Logo

American Heart Association

  2
  0

Final ID:

Meet the Trialist: ZODIAC: Pragmatic Randomized Controlled Trial of a Decision Support System to Aid Physician Optimization of Early Lipid Lowering Therapies after Acute Coronary Syndrome

  • Ray, Kausik  ( IMPERIAL COLLEGE LONDON , London , United Kingdom )
    • Author Disclosures:
    Kausik Ray: DO have relevant financial relationships ; Research Funding (PI or named investigator):sanofi, daiichi sankyo, ultragenix, amarin:Active (exists now) ; Individual Stocks/Stock Options:New Amsteram Pharma, Scribe, Pemi31:Active (exists now) ; Speaker:Novartis, Daiichi, Merck, AZ, Novo Nordisk, BI, Sanofi, Amgen,:Active (exists now) ; Consultant:Kowa, Bayer,:Past (completed) ; Consultant:novartis, daiichi sankyo, AZ, MSD, Esoerion, Scribe, Silence Therapeutics, Cleerly, Nodthera, New Amsterdam Pharma, Amgen, Sanofi, Novo Nordisk, AZ,:Active (exists now) ; Research Funding (PI or named investigator):amgen:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Meet the Trialist: ZODIAC

Monday, 11/18/2024 , 08:45AM - 09:15AM

Meet the Trialist

More abstracts from these authors:
New and Emerging Targets for Lowering LDL-Cholesterol and Triglycerides: ANGPTL3, CETP, APOC-III

Kastelein John, Ray Kausik

How Low and How Fast Should We Go with LDL-Cholesterol?

Ray Kausik, Lloyd-jones Donald, Tokgozoglu Lale

You have to be authorized to contact abstract author. Please, Login
Not Available